The Diagnostic Imaging AI (artificial intelligence) focus page provides information, videos, podcasts, and the latest news about product developments, trial results, screening guidelines, and protocol guidance that touch on the development and use of AI across the healthcare continuum.
September 6th 2024
A machine-learning-based model demonstrated an 87 percent area under the curve and a 90 percent specificity rate for predicting interstitial lung abnormality on CT scans, according to new research.
2023 ASCO Direct™ Highlights: Practice-Changing Data From the Leading Oncology Conference
View More
Satellite Symposia at the Annual Radiation Oncology Meeting
September 28-29, 2024
Register Now!
6th Annual Precision Medicine Symposium: An Illustrated Tumor Board
October 18-19, 2024
Register Now!
Community Practice Connections™: 24th Annual International Lung Cancer Congress®
View More
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 24-26, 2025
Register Now!
Mammography News: FDA Clears AI Software for Breast Arterial Calcification Detection
October 17th 2023Utilized in conjunction with screening digital mammography or digital breast tomosynthesis (DBT), the artificial intelligence (AI)-powered software cmAngio may help detect and localize breast arterial calcification (BAC), an incidental finding that has been linked to an elevated risk for heart disease and stroke.
FDA Clears AI-Enabled Denoising Feature for DWI Sequences on Portable Brain MRI System
October 9th 2023In reportedly the eighth FDA 510(k) clearance for Hyperfine’s Swoop portable brain MRI device, clinicians will now have access to enhanced denoising capabilities with diffusion-weighted imaging (DWI) sequences.
GE HealthCare Adds Real-Time AI Guidance to Venue Family Ultrasound Systems
October 6th 2023Geared to clinicians who may lack ultrasound expertise, the artificial intelligence (AI)-powered Caption Guidance technology reportedly provides stepwise instruction for acquiring optimal cardiac ultrasound images.
Study Shows Mixed Results with AI Software for PE Detection on CTPA Scans
October 5th 2023While the artificial intelligence (AI) triage system significantly reduced wait times for computed tomography pulmonary angiography (CTPA) results that were positive for pulmonary embolism (PE), researchers found no significant differences in the use of adjunctive AI with respect to accuracy rates and specificity rates.
Transformer-Based Multimodal AI Model Improves Diagnosis of Over 20 Conditions with Chest X-Rays
October 3rd 2023Integrating clinical data parameters along with chest X-ray findings, the multimodal artificial intelligence (AI) model outperformed the use of clinical parameters only and chest X-rays only for various conditions ranging from congestive heart failure and chronic kidney disease to hypertension and pneumonia.
CAD Versus AI: Let Me Know When the Alphabet Soup Matters in Radiology
October 2nd 2023Is the continued rise of artificial intelligence (AI) driven by legitimate “machine learning,” or do the frequently “suspicious” chest X-rays and questionable detection of subtle findings on head CTs reveal a hype-driven train of new products with an ultimately “planned obsolescence”?
Study Raises Doubt About AI Sensitivity for Smaller and Multiple Findings on Chest X-Rays
September 29th 2023In a multicenter study examining four commercially available artificial intelligence (AI) software products for chest X-rays in over 2,000 patients, researchers found sensitivity rates ranging between 33 to 61 percent for vague airspace disease and 9 to 94 percent for small pneumothorax and pleural effusion.
New Multicenter Study Shows Viability of AI Tool for Detecting Central PE on CT
September 22nd 2023The Pulmonary Embolism (PE) Triage and Notification (PETN) module with RapidAI’s RapidPE platform reportedly demonstrated over 90 percent sensitivity and specificity rates for detection of central PE on computed tomography (CT), according to multicenter study findings presented at the 9th Annual Pulmonary Embolism Symposium.
Mammography-Based Deep Learning Model Facilitates Higher Breast Cancer Detection on Screening MRI
September 22nd 2023New research suggests the capability of a mammography-based deep learning model to identify women at high risk of breast cancer led to more than triple the cancer detection rate on breast MRI in comparison to traditional risk assessment tools.
FDA Clears AI Software for CT Detection and Triage of Obstructive Hydrocephalus
September 13th 2023Indicated for the triage and notification of obstructive hydrocephalus on non-contrast brain computed tomography (CT), the artificial intelligence (AI)-enabled software is reportedly the first radiology triage modality to obtain the Food and Drug Administration’s (FDA) Breakthrough Device Designation.
Large Mammography Study Suggests AI is Equivalent to Radiologists for Double Reading of Exams
September 11th 2023In a prospective study of over 55,000 women who had screening mammography, researchers found that double-reading by a radiologist and artificial intelligence (AI) was non-inferior to double-reading by two radiologists in detecting breast cancer.
Can AI Match Radiologist Assessment of Screening Mammography Exams?
September 5th 2023In separate test sets that included challenging mammography cases, researchers found that artificial intelligence (AI) demonstrated similar sensitivity and specificity for detecting breast cancer in comparison to assessments from over 500 clinicians.